Discontinued — last reported Q4 '25
Comfort Systems USA Acquisitions decreased by 96.0% to $6.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 91.1%, from $68.41M to $6.10M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 5.3% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.03M | $93.80M | $121.95M | -$3.00K | $39.38M | $9.13M | $710.00K | $53.05M | $357.00K | $0.00 | $48.86M | $196.67M | $37.99M | $809.00K | $0.00 | $68.41M | $55.68M | $4.50M | $151.02M | $6.10M |
| QoQ Change | — | >999% | +30.0% | -100.0% | >999% | -76.8% | -92.2% | >999% | -99.3% | -100.0% | — | +302.5% | -80.7% | -97.9% | -100.0% | — | -18.6% | -91.9% | >999% | -96.0% |
| YoY Change | — | — | — | — | >999% | -90.3% | -99.4% | >999% | -99.1% | -100.0% | >999% | +270.7% | >999% | — | -100.0% | -65.2% | +46.6% | +456.4% | — | -91.1% |